| Literature DB >> 34189470 |
Yihang Jing1, Zheng Liu1, Xiang David Li1.
Abstract
Lysine succinylation is a recently discovered posttranslational modification that plays critical roles in metabolism, epigenetic signaling, and human diseases. To investigate the effects of site-specific histone lysine succinylation on nucleosome dynamics requires the generation of homogeneously modified histones, which is a significant challenge. Here, we report a protocol for the rapid site-specific installation of a succinyl lysine analog onto histone. We then use a Förster resonance energy transfer approach to characterize the impact on nucleosome dynamics. For complete details on the use and execution of this protocol, please refer to Jing et al. (2018).Entities:
Keywords: Biophysics; Chemistry; Molecular Biology; Molecular/Chemical Probes; Protein Biochemistry; Protein expression and purification
Mesh:
Substances:
Year: 2021 PMID: 34189470 PMCID: PMC8215284 DOI: 10.1016/j.xpro.2021.100604
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Scheme 1Synthesis of tert-butyl N-vinyl succinamate
Figure 1Installation of the succinyl lysine analog onto recombinant histone
(A) Scheme for the installation of the succinyl lysine analog (Kcsucc) at position 34 of histone H2B.
(B and C) LC-MS and deconvolution results for the thiol-ene coupling product H2BKc34succ-tBu (B) and the deprotected final product H2BKc34succ (C). Figure reprinted with permission from Jing et al., 2018.
Figure 2The elution profile of H2A-H2B dimers and (H3-H4)2 tetramers in the gel-filtration chromatography detected at 280 nm
H2A-H2B dimers eluted out at around 16 mL, according to its molecular weight (26 kD), whereas (H3-H4)2 tetramers eluted out at around 14.1 mL, according to its molecular weight (53 kD). The purity and stoichiometry of the fractions were verified by 18% SDS-PAGE.
Figure 3Schematics for the stepwise salt dialysis method to reconstitute nucleosomes
The quality and compaction of reconstituted nucleosomes were analyzed by Native-PAGE.
Figure 4The final purified nucleosomes (unmodified and H2BKc34succ, as indicated) used in the FRET experiments
After purification, the amount of free DNA was significantly reduced. Figure reprinted with permission from Jing et al., 2018.
Figure 5Expected outcomes of the FRET experiments
(A) Schematics for a FRET-based approach to study salt-induced stepwise nucleosome disassembly using end-labeled nucleosomal DNA.
(B) Plot showing the normalized FRET intensity as a function of salt concentration for the nucleosomes containing unmodified H2B (black trace) and H2BKc34succ (red trace). The salt concentration at which the FRET has decreased by 50% is denoted as c1/2 (n = 3, mean ± SD).
(C) Schematics for a FRET-based approach with internally labeled nucleosomal DNA.
(D) Plot showing the normalized FRET intensity as a function of salt concentration in nucleosomes containing unmodified H2B (black trace) and H2BKc34succ (red trace). The salt concentration at which the FRET has decreased by 50% is denoted as c1/2 (n = 3, mean ± SD). Figure reprinted with permission from Jing et al. (2018).
| Reagent | Amount |
|---|---|
| AccuPrime™ Pfx DNA Polymerase | 8 μL |
| 20 μM forward primer | 20 μL |
| 20 μM reverse primer | 20 μL |
| Template (50 ng/μL) | 10 μL |
| MgSO4 (50 mM) | 10 μL |
| 10× Buffer | 100 μL |
| up to 1000 μL |
| PCR cycling conditions | |||
|---|---|---|---|
| Steps | Temperature | Time | Cycles |
| Initial Denaturation | 95°C | 3 min | 1 |
| Denaturation | 95°C | 30 sec | 30 cycles |
| Annealing | 50°C | 30 sec | |
| Extension | 68°C | 25 sec | |
| Final Extension | 68°C | 2 min | 1 |
| Hold | 4°C | Forever | |
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| DH5α Competent Cells | Thermo Fisher Scientific | Cat#18265017 |
| Rosetta (DE3) Competent Cells | Novagen | Cat#0954-3CN |
| Fmoc-protected amino acids | GL Biochem | N/A |
| Vinyl iodide | Alfa Aesar | Cat#L12656; CAS: 593-66-8 |
| Alfa Aesar | Cat#L02204; CAS: 110-70-3 | |
| 2,2′-Azobis[2-(2-imidazolin-2-yl) propane] Dihydrochloride (VA-044) | TCI | Cat# A3012; CAS: 27776-21-2 |
| Recombinant proteins | This paper | N/A |
| Bradford assay kit | Bio-Rad | Cat#500-0006 |
| QIAprep Spin Miniprep Kit | QIAGEN | Cat#27104 |
| Slide-A-Lyzer™ MINI Dialysis Device, 3.5K MWCO, 0.5 mL | Thermo Fisher Scientific | Cat#PI88400 |
| Primers for H2B K34C, see primer design | IDT | N/A |
| Primers for fluorophore-labeled DNA fragments, see primer design | IBA GmbH | N/A |
| pET-histone expression plasmids | Prof. Bing Zhu’s lab | N/A |
| OriginPro 8 | OriginLab Corporation | |
| UniDec | University of Oxford | |
| GraphPad Prism 5 | GraphPad Software Inc. | |
| ImageJ | National Institutes of Health | |
| Bioruptor® Sonicator | Diagenode | UCD-300 |
| GENESYS 50 UV-Vis Spectrophotometer | Thermo Fisher Scientific | 840-298000 |
| NanoDrop™ 2000/2000c Spectrophotometers | NanoDrop | ND-2000/2000C |
| ÄKTA pure protein purification system | Cytiva | 29383015 |
| High-Performance Liquid Chromatography | Waters | Waters 2535 Quaternary Gradient Module; Waters 515 HPLC pump; Waters SFO system Fluidics Organizer; Waters 2767 Sample Manager. |
| Agilent 6130 Series Quadrupole LC/MS System | Agilent Technologies | G6130A |
| MaxQ™ HP Incubated Tabletop Orbital Shaker | Thermo Fisher Scientific | SHKE420HP |
| Mini Prep Cell | Bio-Rad | 1702908 |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tryptone | 10 g/L | 10 g |
| Yeast extract | 5 g/L | 5 g |
| NaCl | 10 g/L | 10 g |
| Reagent | Final concentration | Amount |
|---|---|---|
| HEPES | 25 mM | 1.49 g |
| EDTA | 1 mM | 73.06 mg |
| NaCl | 1 M | 14.61 g |
| PMSF | 1 mM | 43.55 mg |
| Reagent | Final concentration | Amount |
|---|---|---|
| Urea | 6 M | 360.36 g |
| HEPES | 25 mM | 5.96 g |
| EDTA | 1 mM | 292.24 mg |
| NaCl | 0/100/500/1000 mM | 0/5.84/29.22/58.44 g |
| Reagent | Final concentration | Amount |
|---|---|---|
| NaH2PO4 | 0.1 M | 599.90 mg |
| Guanidinium HCl | 6 M | 28.66 g |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-HCl | 20 mM | 121.14 mg |
| EDTA | 1 mM | 14.61 mg |
| Guanidinium HCl | 6 M | 28.66 g |
| DTT | 10 mM | 77.13 mg |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-HCl | 10 mM | 1.21 g |
| EDTA | 1 mM | 292.24 mg |
| NaCl | 2 M | 116.88 g |
| β-mercaptoethanol | 5 mM | 390.65 mg |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-HCl | 10 mM | 60.57 mg |
| EDTA | 1 mM | 14.61 mg |
| NaCl | 2 M | 5.84 g |
| β-mercaptoethanol | 5 mM | 19.53 mg |
| Glycerol | 50% (v/v) | 1 L |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-HCl | 10 mM | 2.42 g |
| EDTA | 0.1 mM | 58.44 mg |
| KCl | 2 M | 298.21 g |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-HCl | 10 mM | 605.70 mg |
| EDTA | 0.1 mM | 14.61 mg |
| KCl | 1.6 M/1.4 M/1.2 M/1.0 M/0.8 M/0.5 M/0.2 M/10 mM | 59.64 g/52.19 g/44.73 g/37.28 g/29.82 g/18.64 g/7.46 g/372.76 mg |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-HCl | 62.5 mM | 15.14 mg |
| Bromophenol Blue | 0.01% (w/v) | 200 μL 0.1% stock |
| Glycerol | 40% (v/v) | 0.8 mL |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-borate | 45 mM | 8.23 g |
| EDTA | 1 mM | 292.24 mg |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-HCl | 10 mM | 1.21 g |
| EDTA | 0.1 mM | 29.22 mg |
| KCl | 10 mM | 745.51 mg |
| Glycerol | 10% (v/v) | 100 mL |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-HCl | 10 mM | 605.70 mg |
| EDTA | 0.1 mM | 14.61 mg |
| NaCl | 2 M | 58.44 g |
| Ascorbic acid | 1 mM | 88.06 mg |
| BSA | 0.1 g/L | 50 mg |
| Reagent | Final concentration | Amount |
|---|---|---|
| Tris-HCl | 10 mM | 605.70 mg |
| EDTA | 0.1 mM | 14.61 mg |
| NaCl | 10 mM | 292.20 mg |
| Ascorbic acid | 1 mM | 88.06 mg |
| BSA | 0.1 g/L | 50 mg |
| Solution | Contents | Storage |
|---|---|---|
| 10 M NaOH | 20 g NaOH, fill up to 50 mL with Milli-Q water | 22°C–25°C, up to 6 months |
| 1 M DTT stock solution | 771.27 mg DTT, fill up to 5 mL with Milli-Q water | −20°C, up to 6 months |
| HPLC Buffer A | 1 mL TFA, fill up to 1 L with Milli-Q water | 22°C–25°C, up to 2 months |
| HPLC Buffer B | 1 mL TFA, fill up to 1 L with 90% acetonitrile (ACN) in Milli-Q water | 22°C–25°C, up to 2 months |
| Final salt concentration/M | FRET experimental high salt buffer (V/μL) | FRET experimental low salt buffer (V/μL) | nucleosome solution (V/μL) |
|---|---|---|---|
| 0.01 | 0 | 190 | 10 |
| 0.1 | 10 | 180 | 10 |
| 0.2 | 20 | 170 | 10 |
| 0.3 | 30 | 160 | 10 |
| 0.4 | 40 | 150 | 10 |
| 0.5 | 50 | 140 | 10 |
| 0.6 | 60 | 130 | 10 |
| 0.7 | 70 | 120 | 10 |
| 0.8 | 80 | 110 | 10 |
| 0.9 | 90 | 100 | 10 |
| 1.0 | 100 | 90 | 10 |
| 1.1 | 110 | 80 | 10 |
| 1.2 | 120 | 70 | 10 |
| 1.3 | 130 | 60 | 10 |
| 1.4 | 140 | 50 | 10 |
| 1.5 | 150 | 40 | 10 |
| 1.6 | 160 | 30 | 10 |